Age-Specific Pharmacotherapy Considerations in Older-Age Bipolar Disorder
This narrative review synthesizes diagnostic and pharmacologic considerations for bipolar disorder in older adults, an understudied population where standard evidence is largely extrapolated from younger cohorts.
Bipolar disorder in older adults demands unique pharmacotherapy approaches.
Bipolar disorder in older adults often presents atypically, complicating diagnosis and requiring age-specific pharmacotherapy considerations due to altered pharmacokinetics and increased risk of drug interactions. Mood stabilizers and atypical antipsychotics are used, but their use in older adults needs careful monitoring due to polypharmacy and comorbidities. While LOBD and EOBD subgroups exist, pharmacologic management is similar; the study emphasizes a need for age-specific trials to improve outcomes. Managing bipolar disorder in older adults requires careful pharmacotherapy, considering age-specific challenges.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Asir B, Al-Soleiti M, Singh B
Citation:Asir B, Al-Soleiti M, Singh B Bipolar Disorder in Older Adults: A Comprehensive Overview of Pharmacotherapy Patterns and Clinical Considerations. Drugs & aging. 2026;43(8):707-720. doi:10.1007/s40266-026-01315-8